Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General & Administrative Expenses (SG&A) | $4,242.0K | $5,730.0K | $25.7M | $8,455.0K | $5,063.0K | $9,840.0K | $10.3M | $12.2M | $12.7M | $22.2M | $31.1M | $43.2M | $50.7M | $79.2M | $168.2M | $210.8M | $203.6M | $234.3M | $265.8M | $344.5M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Insmed Incorporated's last 12-month Selling, General & Administrative Expenses (SG&A) is $461.1M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Insmed Incorporated's Selling, General & Administrative Expenses (SG&A) growth was 33.9%. The average annual Selling, General & Administrative Expenses (SG&A) growth rates for Insmed Incorporated have been 29.7% over the past three years, 16.9% over the past five years.
Over the last year, Insmed Incorporated's Selling, General & Administrative Expenses (SG&A) growth was 33.9%, which is higher than industry growth of 0.0%. It indicates that Insmed Incorporated's Selling, General & Administrative Expenses (SG&A) growth is Bad.